Olav Steinnes

CardiNor AS develops, produces, and sells in-vitro diagnostic products. It establishes a blood test for elevated levels of Secretoneurin that may indicate that a patient has a heart disease. The company was founded on June 25, 2015 and is headquartered in Oslo, Norway.

Ostomycure AS develops solution for evacuating of fluids from the intestines. It include product called TIES is used for patients that have their colon or urinary bladder removed and thus need to get rid of the waste from the ileum in another fashion than the normal way. The company was founded by Bente Buveruds in 2003 and is headquartered in Oslo, Norway.

Orphan Diagnostics AS engaged in the provision of focusing on point-of-care diagnostics in clinical toxicology. The company was founded in 2016 and is headquartered in Oslo, Norway.

Orphan Diagnostics AS engaged in the provision of focusing on point-of-care diagnostics in clinical toxicology. The company was founded in 2016 and is headquartered in Oslo, Norway.

Prosa Security AS develops cyber security software. Its products r include risk analysis report, system overview, Security in vendor applications, mobile application Security tool and software development Security and It offers feasibility study, training and consulting services. The company was founded in 2015 and is headquartered in Oslo, Norway.

Prosa Security AS develops cyber security software. Its products r include risk analysis report, system overview, Security in vendor applications, mobile application Security tool and software development Security and It offers feasibility study, training and consulting services. The company was founded in 2015 and is headquartered in Oslo, Norway.

CardiNor AS develops, produces, and sells in-vitro diagnostic products. It establishes a blood test for elevated levels of Secretoneurin that may indicate that a patient has a heart disease. The company was founded on June 25, 2015 and is headquartered in Oslo, Norway.

ProfMOF AS manufactures metal organic frameworks. The company was founded by Sachin Maruti Chavan, Unni Olsbye, Karl Petter Lillerud and Norbert Stock in 2015 and is headquartered in Kongsberg, Norway.

CardiNor AS develops, produces, and sells in-vitro diagnostic products. It establishes a blood test for elevated levels of Secretoneurin that may indicate that a patient has a heart disease. The company was founded on June 25, 2015 and is headquartered in Oslo, Norway.

Ostomycure AS develops solution for evacuating of fluids from the intestines. It include product called TIES is used for patients that have their colon or urinary bladder removed and thus need to get rid of the waste from the ileum in another fashion than the normal way. The company was founded by Bente Buveruds in 2003 and is headquartered in Oslo, Norway.

Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials.

Ostomycure AS develops solution for evacuating of fluids from the intestines. It include product called TIES is used for patients that have their colon or urinary bladder removed and thus need to get rid of the waste from the ileum in another fashion than the normal way. The company was founded by Bente Buveruds in 2003 and is headquartered in Oslo, Norway.

CardiNor AS develops, produces, and sells in-vitro diagnostic products. It establishes a blood test for elevated levels of Secretoneurin that may indicate that a patient has a heart disease. The company was founded on June 25, 2015 and is headquartered in Oslo, Norway.

CardiNor AS develops, produces, and sells in-vitro diagnostic products. It establishes a blood test for elevated levels of Secretoneurin that may indicate that a patient has a heart disease. The company was founded on June 25, 2015 and is headquartered in Oslo, Norway.

Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials.

Ostomycure AS develops solution for evacuating of fluids from the intestines. It include product called TIES is used for patients that have their colon or urinary bladder removed and thus need to get rid of the waste from the ileum in another fashion than the normal way. The company was founded by Bente Buveruds in 2003 and is headquartered in Oslo, Norway.

Ostomycure AS develops solution for evacuating of fluids from the intestines. It include product called TIES is used for patients that have their colon or urinary bladder removed and thus need to get rid of the waste from the ileum in another fashion than the normal way. The company was founded by Bente Buveruds in 2003 and is headquartered in Oslo, Norway.

Prosa Security AS develops cyber security software. Its products r include risk analysis report, system overview, Security in vendor applications, mobile application Security tool and software development Security and It offers feasibility study, training and consulting services. The company was founded in 2015 and is headquartered in Oslo, Norway.

Ostomycure AS develops solution for evacuating of fluids from the intestines. It include product called TIES is used for patients that have their colon or urinary bladder removed and thus need to get rid of the waste from the ileum in another fashion than the normal way. The company was founded by Bente Buveruds in 2003 and is headquartered in Oslo, Norway.

Prosa Security AS develops cyber security software. Its products r include risk analysis report, system overview, Security in vendor applications, mobile application Security tool and software development Security and It offers feasibility study, training and consulting services. The company was founded in 2015 and is headquartered in Oslo, Norway.

CardiNor AS develops, produces, and sells in-vitro diagnostic products. It establishes a blood test for elevated levels of Secretoneurin that may indicate that a patient has a heart disease. The company was founded on June 25, 2015 and is headquartered in Oslo, Norway.